Evidence map›Paper›PMID 41441934›Full record

ArticleAnnals of surgical oncology2026

Selective Artery Clamping Superior to Main Artery Clamping in Preserving Ipsilateral Renal Function after Minimally Invasive Partial Nephrectomy under Prolonged Warm Ischemia.

Xiangpeng Zou, Xiaofeng Yang, Yunhan Luo, Rongliang Zheng, Shaohan Yin, Jian Wu, Zhaohui Zhou, Yulu Peng, Xin Luo, Lihao Zhang and 6 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Xiangpeng Zou *Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xiaofeng Yang *Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yunhan Luo *Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Rongliang ZhengState Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Shaohan YinState Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
Jian WuDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Zhaohui ZhouDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yulu PengDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xin LuoDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Lihao ZhangDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Pei DongDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Hui HanDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Shengjie GuoDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Fangjian ZhouDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Longbin XiongDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. xionglb@sysucc.org.cn.
Zhiling ZhangDepartment of Urology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. zhangzhl@sysucc.org.cn.

Funding

Guangzhou Municipal Science and Technology Project 2024A04J4319National Natural Science Foundation of China 82273031National Natural Science Foundation of China 82273311National Natural Science Foundation of China 82303922National Natural Science Foundation of China 82373225National Natural Science Foundation of China 82472655Natural Science Foundation of Guangdong Province 2024A1515010303
6 · The paper itself

Abstract

backgroundThe renal functional advantages of selective artery clamping (SAC) compared with main artery clamping (MAC) remain inconsistent. This study aimed to assess the impact of SAC versus MAC on ipsilateral renal function after minimally invasive partial nephrectomy (MIS-PN) in patients with bilateral kidneys. PATIENTS AND

methodsThis study included 692 patients with bilateral kidneys who underwent ipsilateral clamped MIS-PN using either SAC or MAC, with available imaging, serum creatinine, and split renal function measured at defined pre- and postoperative time points. Propensity score matching (PSM, 1:2) was performed to balance baseline characteristics. Spectrum score was used to assess the degree of acute ipsilateral renal dysfunction. Recovery from ischemia (Rec

resultsAfter PSM, 365 patients were analyzed (125 SAC/240 MAC). In the limited ischemia cohort (warm ischemia time [WIT] ≤ 30 min) (94 SAC/177 MAC), no significant differences were observed between the SAC and MAC groups in the spectrum score (0.1 vs. 0.1, p = 0.66) or Rec

conclusionsUnder prolonged WIT, SAC afforded superior ipsilateral renal function preservation compared with MAC in patients with bilateral kidneys, which guides experienced surgeons in optimizing MIS-PN strategies for patients with complex renal masses.

Indexed as

KidneyKidney NeoplasmsMinimally Invasive Surgical ProceduresNephrectomyOrgan Sparing TreatmentsRenal ArteryWarm IschemiaAgedConstrictionFemaleFollow-Up StudiesGlomerular Filtration RateHumansMaleMiddle AgedPrognosisAcute ipsilateral renal dysfunctionMain renal clampingPartial nephrectomyRecovery from ischemiaSelective artery clampingWarm ischemia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.